Pain Control of Thoracoscopic Major Pulmonary Resection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-31

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether pre-emptive local bupivacaine injection is a better alternative pain control modality than the conventional intravenous patient controlled analgesia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Block and Erector Comparative Study Between Costotransverse Spinae Plane Block in Patients Undergoing Thoracotomy

NCT06301334

Pain Mangement of Thoracotomy

NOT_YET_RECRUITING NA

Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study

NCT02287623

Acute Pain

COMPLETED PHASE4

Preventive Skin Analgesia With Lidocaine Patch 5% for Controlling Post-thoracotomy Pain

NCT02751619

Pain, Postoperative

COMPLETED NA

A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery

NCT06529432

Local Analgesia Via Nerve Block

NOT_YET_RECRUITING PHASE2

Liposomal vs. Conventional Bupivacaine for Pain Control

NCT06231355

Local Anesthetics Analgesia Regional Block +1 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Despite less postoperative pain from Video Assisted Thoracic Surgery (VATS) than thoracotomy, pain is still an important issue in its recovery period. After VATS procedure, intravenous patient controlled analgesia (IV PCA) is being used for pain control. However, the side effects of IV PCA are nausea, vomiting, sleepiness, and urination difficulty which interrupt the early recovery. It is established that pre-emptive local bupivacaine injection is more economical, has almost no side effects, and finally, it is effective for the postoperative 24 hours. The purpose of this study is to evaluate whether pre-emptive local bupivacaine injection is a better alternative pain control modality than the conventional intravenous patient controlled analgesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bupivacaine

Group Type ACTIVE_COMPARATOR

Pre-emptive bupivacaine wound infiltration

Intervention Type PROCEDURE

Pre-emptive bupivacaine wound infiltration

Intravenous Patient Controlled Analgesia

postoperative pain control with intravenous patient controlled analgesia

Group Type OTHER

intravenous patient controlled analgesia

Intervention Type PROCEDURE

postoperative pain control with intravenous patient controlled analgesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pre-emptive bupivacaine wound infiltration

Intervention Type PROCEDURE

intravenous patient controlled analgesia

postoperative pain control with intravenous patient controlled analgesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients that are expected to receive VATS segmenectomy or lobectomy regardless of disease entity

Exclusion Criteria

* not done by VATS anatomical resection
* patient does not agree to the study
* postoperative hospital stay exceeds 7 days due to postoperative complications
* existence of preoperative renal insufficiency (Cr \> 1.5)
* OT/PT \> 120
* history of Lidocaine hypersensitivity

Eligible Sex

ALL

Accepts Healthy Volunteers

No